PRESS RELEASE: Public as of January 8, 2007

January 8, 2007 Fort Worth, Texas:
US DNA, Inc. (www.USDNABiotech.com) of Fort Worth, Texas announced an expansion of its corporate base with the addition of an international alliance to provide high-quality Thermostable DNA Polymerases and other biotech reagents for use in PCR (Polymerase Chain Reaction), high throughput applications and processes such as MALDI-TOF, MassARRAY, etc.

Duke Nishimura, President and CEO of US DNA, Inc. announced the strategic alliance in an online press conference January 8, 2007 in Fort Worth, Texas. Mr. Nishimura stated, �This international corporate alliance adds leverage to provide large clients a competitive edge in the biotechnology market while still maintaining the ability to provide individual users great value to extend their budget. USDNA now has the ability to provide large companies technology licensing options to expand their product lines, create an OEM relationship with exclusive advantages as well as Private Label options at a price that is a win-win-win for end-users, providers and beneficiaries of the DNA industry.� Mr. Nishimura added, “For current producers of enzymes, USDNA can provide equal, or in many cases higher-yield, products at a price that retains the original manufacturers’ margins without the capitalization expenses. For end users, we can provide increased cycle endurance, efficiency, success rates as well as convenient room-temperature storage during use for extended periods without degradation. The net result may be a major benefit in extending research outcomes, accuracy and budgets.�

US DNA, Inc. also announced a special Two-for-One campaign on many of its products to celebrate the new opportunities created by this alliance and to share the new success with the end users and clients.

Although US DNA, Inc. is a privately held company, leverage advantages can be obtained for companies of all types:

*For additional information on products see US DNA’s web site at www.USDNABiotech.com.  

*For information on OEM, Private Label or Supply Sourcing contact email@USDNABiotech.com.

*For investor relations, please contact InvestorRelations@USDNABiotech.com.



Press Release Contact: Email@USDNABiotech.com